Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study was to determine the improvement in nutritional status, especially in the level of insulin-like growth factor-1 (IGF-1) and its relationship with changes in the circulating cytokine levels, after providing extra protein and energy contents to community-dwelling older adults at risk of undernutrition.
Sixty of aged over 65 years, living independently in the community for elderly people, nondiabetic subjects with serum prealbumin of under 30 mg/dL and BMI under 25 kg/m2 were recruited. The subjects were followed for a 2-week pre-intervention period, followed by an intervention period, which they received 2 cartons of liquid oral nutritional supplementation daily for 2 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single-arm pretest-posttest | Experimental | In this study, the subjects served as their own controls. Subjects who were eligible based on inclusion criteria first entered into a 2-week pre-intervention period, during which they received nutrition counseling to keep their routine dietary habits. This was followed by an intervention period, during which an oral nutritional supplement was used over a period of 2 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pre-intervention | Dietary Supplement | First 2-weeks : keeping routine dietary habit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Prealbumin (mg/dL) | at pre-treatment (week -2) | |
| Prealbumin (mg/dL) | at baseline (week 0) | |
| Prealbumin (mg/dL) | at post-treatment (week 2) | |
| Transferrin (mg/dL) | at pre-treatment (week -2) | |
| Transferrin (mg/dL) | at baseline (week 0) | |
| Transferrin (mg/dL) | at post-treatment (week 2) |
| Measure | Description | Time Frame |
|---|---|---|
| Weight (kg) | 3 times during 4 weeks : at pre-treatment (week -2) / at baseline (week 0) / at post-treatment (week 2) | 4 weeks |
| Body mass index (kg/m2) | 3 times during 4 weeks : at pre-treatment (week -2) / at baseline (week 0) / at post-treatment (week 2) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jong Ho Lee, Ph.D. | Department of Food & Nutrition, College of Human Ecology, Yonsei University 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea | Study Director |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27933679 | Derived | Kim M, Kim M, Lee YJ, Song HJ, Shim JK, Chang DH, Yu WK, Lee SH, Lee JH. Supplementation with nutrients modulating insulin-like growth factor-1 negatively correlated with changes in the levels of pro-inflammatory cytokines in community-dwelling elderly people at risk of undernutrition. J Hum Nutr Diet. 2017 Feb;30(1):27-35. doi: 10.1111/jhn.12447. Epub 2016 Dec 9. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D044342 | Malnutrition |
| ID | Term |
|---|---|
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Liquid nutritional supplement | Dietary Supplement | Pre-intervention period was followed by an intervention period, during which consumed twice-daily 200 mL cartons of oral liquid nutritional supplementation (total 400 mL daily, containing 16 g protein, 12 g fat and 60 g carbohydrate and providing 400 kcal) |
|
| 4 weeks |
| Serum albumin (g/dL) | 3 times during 4 weeks : at pre-treatment (week -2) / at baseline (week 0) / at post-treatment (week 2) | 4 weeks |
| Insulin growth factor-1 (ng/mL) | 3 times during 4 weeks : at pre-treatment (week -2) / at baseline (week 0) / at post-treatment (week 2) | 4 weeks |
| Osmolality (mOsm/kgH2O) | 3 times during 4 weeks : at pre-treatment (week -2) / at baseline (week 0) / at post-treatment (week 2) | 4 weeks |